Caricamento...
Effectiveness and safety of rhIGF1 therapy in patients with or without Laron syndrome
OBJECTIVE: The European Increlex(®) Growth Forum Database Registry monitors the effectiveness and safety of recombinant human insulin-like growth factor-1 (rhIGF1; mecasermin, Increlex(®)) therapy in patients with severe primary IGF1 deficiency (SPIGFD). We present data from patients with and withou...
Salvato in:
| Pubblicato in: | Eur J Endocrinol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Bioscientifica Ltd
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7849377/ https://ncbi.nlm.nih.gov/pubmed/33434161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EJE-20-0325 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|